Evidence map›Paper›PMID 41141352›Full record

SynthesisFrontiers in endocrinology2025

Association of systemic immune-inflammation index with type 2 diabetes mellitus and its prognostic significance: a systematic review and meta-analysis.

Ru Xu, Lele Jiang

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ru XuDepartment of Clinical Laboratory, Beilun People's Hospital, Ningbo, Zhejiang, China.
Lele JiangDepartment of Clinical Laboratory, Beilun People's Hospital, Ningbo, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The systemic immune-inflammation index (SII), a novel biomarker, may be associated with type 2 diabetes mellitus (T2DM). This study aimed to investigate the relationship between SII and T2DM, as well as its prognostic value. Methods: A comprehensive search of PubMed, Embase, Cochrane Library, Web of Science, CNKI, VIP, Wanfang, and Biomedical Literature Database was conducted to identify eligible studies published up to October 26, 2024. Relative risk (RR), odds ratio (OR), and hazard ratio (HR), along with their 95% confidence intervals (CIs), were extracted and synthesized. Statistical analyses were performed using Stata 15.1 software. Results: 21 studies were included. SII was associated with an increased risk of major adverse cardiovascular events (MACE) and mortality. Each one-unit standard deviation (SD) increase in SII was positively correlated with MACE risk (OR/HR = 1.07; 95% CI: 1.04-1.10; Conclusions: Elevated SII is associated with an increased risk of MACE, mortality, diabetic nephropathy and glucose metabolism abnormalities but shows no significant correlation with diabetic retinopathy.

Indexed as

Diabetes Mellitus, Type 2InflammationBiomarkersCardiovascular DiseasesHumansPrognosisBiomarkersassociationmeta-analysisprognosissystemic immune-inflammation indextype 2 diabetes mellitus

Identifiers

PMID41141352
PMCPMC12548759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.